W A Kukull
Overview
Explore the profile of W A Kukull including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
6373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adam A, Robison J, Lu J, Jose R, Badran N, Vivas-Buitrago T, et al.
Fluids Barriers CNS
. 2017 Sep;
14(Suppl 1):15.
PMID: 28929972
No abstract available.
2.
Maddox R, Blase J, Mercaldo N, Harvey A, Schonberger L, Kukull W, et al.
Am J Alzheimers Dis Other Demen
. 2015 Aug;
30(8):752-5.
PMID: 26320231
Background: Brain tissue analysis is necessary to confirm prion diseases. Clinically unsuspected cases may be identified through neuropathologic testing. Methods: National Alzheimer's Coordinating Center (NACC) Minimum and Neuropathologic Data Set...
3.
Jun G, Ibrahim-Verbaas C, Vronskaya M, Lambert J, Chung J, Naj A, et al.
Mol Psychiatry
. 2015 Mar;
21(1):108-17.
PMID: 25778476
APOE ɛ4, the most significant genetic risk factor for Alzheimer disease (AD), may mask effects of other loci. We re-analyzed genome-wide association study (GWAS) data from the International Genomics of...
4.
Berres M, Kukull W, Miserez A, Monsch A, Monsell S, Spiegel R
J Prev Alzheimers Dis
. 2014 Dec;
1(2):99-109.
PMID: 25530953
Introduction: The PGSA (Placebo Group Simulation Approach) aims at avoiding problems of sample representativeness and ethical issues typical of placebo-controlled secondary prevention trials with MCI patients. The PGSA uses mathematical...
5.
Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C, et al.
Nat Genet
. 2013 Oct;
45(12):1452-8.
PMID: 24162737
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains unexplained. We conducted a large,...
6.
Koepsell T, Kurland B, Harel O, Johnson E, Zhou X, Kukull W
Neurology
. 2007 Dec;
70(19 Pt 2):1732-9.
PMID: 18160675
Background: Education may modulate the degree to which the neuropathology of Alzheimer disease (AD) is expressed as impaired cognitive performance. Methods: We studied 2,051 participants age 65+ years at 27...
7.
Koepsell T, Chi Y, Zhou X, Lee W, Ramos E, Kukull W
Neurology
. 2007 Nov;
69(19):1868-72.
PMID: 17984455
Background: In a randomized trial of AN1792 vaccine against A beta in Alzheimer disease (AD), only 20% of vaccine recipients had an anti-AN1792 antibody response. The trialists sought to estimate...
8.
Tirschwell D, Kukull W, Longstreth Jr W
J Stroke Cerebrovasc Dis
. 2007 Sep;
8(5):336-43.
PMID: 17895183
Background: Medical complications of ischemic stroke can increase length of hospital stay (LOS). Stroke clinical pathways aim to reduce costs by decreasing LOS through standardization of care and avoidance of...
9.
Li G, Shofer J, Kukull W, Peskind E, Tsuang D, Breitner J, et al.
Neurology
. 2005 Oct;
65(7):1045-50.
PMID: 16217057
Objectives: To examine the association of serum total cholesterol (TC) and high density lipoprotein (HDL) levels and subsequent incidence of dementia and Alzheimer disease (AD) in a population-based cohort study....
10.
Kraybill M, Larson E, Tsuang D, Teri L, McCormick W, Bowen J, et al.
Neurology
. 2005 Jun;
64(12):2069-73.
PMID: 15985574
Objective: To examine the neuropsychological profile of dementia patients from a community-based autopsy sample of dementia, comparing Alzheimer disease (AD), Lewy body pathology (LBP) alone, and LBP with coexistent AD...